The US Environmental Protection Agency (EPA) is facing a future in which its hands will be tied on making many policies if a new bill becomes law.
Last week the US House of Representatives passed a bill, the HONEST Act, that would prevent the EPA from basing any of its regulations on science that is not publicly accessible – not just journal articles themselves, but all of the underlying data, models and computer code. Read more in New Scientist.
An overview of biomedical research in the USA—the major funders, trends, and strengths and weaknesses facing the world’s major scientific superpower.
The biomedical research landscape in the USA is so vast and comprehensive that it can be difficult to get a handle on specifics. But within the expanse of the biomedical specialty, there are a few unique aspects that stand out.
America is a leader in funding for biomedical research, from government, industry, and the non-profit sector. And, for such a large country, the research community is remarkably spread out, with high-quality work being done in every region of the nation. But the dominance of the USA is slowly being challenged by the rise in both volume and quality of research done in other countries, though it will be some time yet before any challenger will be able to seize the top spot. Read more in The Lancet.